トップページ

ナルコケミカルカンパニー（Nalco Chemical Company）

1928年　　ナショナルアルミネートコーポレーションが誕生
　　　　　　　　　　シカゴケミカルカンパニー/アルミネートセールスコーポレーション合併
　　　　　　　　　　　　水処理剤のパイオニア

1959年　　ナルコケミカルカンパニーと改称

2003 　　　 Nalco Aquisition By Private Equity Group Complete

　　　　　The Blackstone Group, Apollo Management L. P. and Goldman Sachs Capital Partners buy Ondeo Nalco.

２００４　Nalco returns to trading on the New York Stock Exchange following an IPO on November 11, 2004.

フィリップス・ペトローリアム・カンパニー（ＰＨｌＬＬｌＰＳ　ＰＥＴＲＯＬＥＵＭ　ＣＯＭＰＡＮＹ）

２０００年７月　シェブロン・フィリップス・ケミカル・カンパニー　発足

2002/8/30 ConocoPhillips Merger Completed

　　Conoco and Phillips Agree to Merger of Equals to form ConocoPhillips.

ライオンデルケミカルカンパニー（Ｌｙｏｎｄｅｌｌ Ｃｈｅｍｉｃａｌ Ｃｏｍｐａｎｙ）

１９８５年　アトランチック・リッチフィールド社（ＡＲＣＯ　のちＢＰが買収）の一部門として設立
８７年１０月　独立企業

直接酸化法（ＰＯ／ＳＭ，ＰＯ／ＴＢＡ）によるプロピレンオキサイド事業で飛躍的に発展
　　ＭＴＢＥの世界トップメーカー
　　ＳＭの米国最大の外販メーカー

９６年　米オーリンからＴＤＩ事業買収

９８年７月、旧アーコ・ケミカルがライオンデル・ケミカルと合併

出資先：
　石油精製企業のライオンデルＣＩＴＧＯリファイニング（ライオンデル５８．７５％出資）
　メタノールメーカーのライオンデル・メタノール（ライオンデル７５％出資）
　オレフィンおよぴポリオレフィンメーカーのエクイスター・ケミカルズ
　　　　（９７年１２月設立、ライオンデル４１％、ミレニアムとオキシデンタルが各２９．５％出資
　　　　　→ 2002年LyondellがOccidental持株を購入）
　　　　　　　　　　　＊OccidentalがLyondell株を購入

Lyondell and Millennium 統合発表 　　　両社概要

Lyondell / Millennium 　2004/12/1に統合

Lyondell Completes Acquisition of Millennium Chemicals

Access Industries （Basell買収）の会長、Lyondellの株式 8.3% 買収へ

http://www.lyondell.com/html/lyondell/history.shtml

2005/10 　Lyondell to Permanently Cease TDI Production at Lake Charles Plant

2007/2 Lyondell Announces Approval for New PO/SM Facility in Ningbo, China

2007/2　Lyondell Announces Sale of TiO2 Business to National Titanium Dioxide Company Ltd. (Cristal)

2007/4 Inauguration Ceremony of Ningbo ZRCC Lyondell Chemical Co. Ltd. in Beijing

2007/7　Basell to acquire Lyondell Chemical Company

　　　　Equistar spends $125 million correcting environmental violations

2007/8　POの価格裁判でLyondell がBASFに敗訴、 $170 million支払の判決

2007/10 LyondellBasell Industries to be new company name

2008/3 Rhodia and Lyondell enter into exclusive negotiations with Perstorp for the sale of their isocyanates business

ローデイア（ＲＨＯＤｌＡ　Ｓ．Ａ．） 　　　　　2011/4/12　Solvay、Rhodiaを友好的買収

　　　　Sale of European chemicals unit

１９６１年　ローヌ・プーラン（Rhone-Poulenc） として創立
８２年　フランス大企業の国有化政策によって、国有化
９３年１月・１１月　２段階民営化策により、再び民営企業

９７年１２月　ライフサイエンスと特殊化学品の２事業を明確化する決定
　　　　　本体はHoechstと合併してAventis
　　　　　化学品事業部と繊維・ポリマー事業部を統合、９８年１月　新会社ローディアを設立

Rhodia Opens Its New Engineering Plastics Plant in China

Rhodia signs letter of intent with China National Blue Star Corporation for a strategic alliance in Silicone Activities

Rhodia signs agreement for the sale of its silicones business to China National Bluestar Corporation

Rhodia completes sale of its Silicones business to China National BlueStar Corporation

Rhodia to build a Diphenols plant in China

Rhodia continues its development in Asia with the construction of a new polyamide unit in South Korea

Rhodia expands upstream in Chinese polyamides

Rhodia and Snia sell stake in Nylstar

Rhodia signs agreement for the sale of its silicones business to China National Bluestar Corporation

Rhodia To Build An Upstream Silica Facility In China

Rhodia to construct new high performance silica plant in China

Rhodia Polyamide South Korea Polymerization Unit Construction on Schedule

Rhodia and Lyondell enter into exclusive negotiations with Perstorp for the sale of their isocyanates business

Rhodia announces a plan to improve the competitiveness of its polyamide businesses in Europe

Rhodia to acquire Feixiang Chemicals (ZJG), China's leading producer of amines and surfactants

ローディア、山東省青島の新しいシリカ工場で生産開始

Rhodia to accelerate its growth in India with the acquisition of PI Industries' engineering plastics business

Rhodia expands Chicago silica plant

---

10/25/2004 Rhodia

Rhodia Polyamide announces the building of a new State-of-the-Art engineering plastics Plant in China
http://www.rhodia-ep.com/ep/nw_press_release_detail.jsp?CONTENT%3C%3Ecnt_id=10134198673402371&FOLDER%3C%3Efolder_id=2534374302192739&bmUID=1117180950245

Today, Rhodia Polyamide has announced its decision to build a new engineering plastics compounding facility at its Shanghai site in China.

This new facility reinforces Rhodia Polyamide's commitment to growth in China and more generally in Asia. Rhodia Polyamide will have the expertise to produce the full spectrum of compounded products including Technyl® PA6, PA66 and PA 66/6, Technyl Star^TM, as well as Technyl® Alloy and other engineering thermoplastics.


The new facility is designed to accommodate future Chinese production requirements that are anticipated to grow at approximately 20% per year. The new compounding plant will produce approximately 40 000 T at full capacity and further confirms Rhodia Polyamide's commitment to maintaining a leadership position in Engineering Plastics.

---

2005/5/27

Rhodia Opens Its New EP Plant in China

On May 18, 2005 Rhodia Polyamide has celebrated the groundbreaking of its new engineering plastics compounding facility at its Shanghai site in China.

---

2006/9/24 British Plastics & Rubber

Rhodia expands upstream in Chinese polyamides

Rhodia is building a hexamethylene diamine unit in China as part of its upstream integration in the polyamide chain. It will have an annual capacity of 60,000 tonnes and will be operational in early 2009. The company is also studying the feasibility of building an adiponitrile plant in Asia.

---

Platts 2003/1/3

Rhodia completes sale of European chemicals unit to Bain

French specialty chemicals maker Rhodia SA, has completed the sale of its European basic chemicals unit to investment firm Bain Capital Ltd for an undisclosed amount, the company announced Friday.

---

2005/4/4 Rhodia

RHODIA TO BUILD A DIPHENOLS PLANT IN CHINA
Investment will strengthen leadership position in core technology

Rhodia announces an investment to further strengthen its leadership position in the Diphenols business by building a new production plant for catechol and hydroquinone in China. The manufacturing facility which will be located near Shanghai will have an estimated annual production capacity of about 12,000 tons and is scheduled to be on-stream in early 2007.

The Rhodia Perfumery, Performance & Agro (PPA) Enterprise, specializing in organic chemistry, is refocusing its business portfolio on three product trees, in which it holds strong market and technology leadership positions:
・Diphenols and derivatives
・Salicylic acid product line
・Trifluoroacetic acid (TFA) and fluorination.

---

2006/4/20 Rhodia

Rhodia continues its development in Asia with the construction of a new polyamide unit in South Korea

Rhodia has announced the construction of a polymerization unit at its integrated production platform in Onsan (South Korea). With an annual capacity of 48,000 tonnes, the unit will start polyamide production at the end of 2007. This investment of almost 40 million euros will strengthen the market position of Rhodia in Asia .

The new facility will produce nylon salt and polyamide 6.6 polymers. With their mechanical and thermal properties these are used in engineering plastics and industrial fibers for the automotive, electricity and electronics or the consumer goods industries.

1998/1　Rhone Poulenc の化学品事業部と繊維・ポリマー事業部を統合、新会社ローディアを設立

---

2007/3/6　Rhodia

Rhodia sells stake in Nylstar

Rhodia announces today the signing of an agreement to sell its 50% stake in Nylstar for Euro 1, to a third party agent acting on behalf of a consortium of Nylstar's credit banks. SNIA, Rhodia's partner in this joint venture , has also signed an agreement to sell its 50% stake. The sale of the stake in Nylstar will be effective once the necessary regulatory formalities have been completed.

This agreement forms part of the financial restructuring of Nylstar through a debt / equity swap to give the company a restructured balance sheet and a significantly reduced level of debt. Nylstar will now be in a better position to ensure its development. Rhodia will also remain a raw material supplier to Nylstar.

---

British Plastics & Rubber 2007/3/6

Rhodia and Snia finally escape from Nylstar

Rhodia of France and Snia of Italy have finally pulled out of their ailing nylon fibre joint venture Nylstar. They have sold their 50 per cent stakes for a token Eur 1 to a consortium of Nylstar's creditors.
Rhodia has been trying to free itself from the fibres business for several years and has been counting on Radici of Italy to buy it out. Radici, Rhodia and Snia planned early in 2005 to ally Nylstar with RadiciFibres, with Radici taking a majority.

Aventis　

Aventis was created through the December 1999 business combination of Hoechst and Rhône-Poulenc. We are transforming Aventis into a pure pharmaceutical company through the divestiture of the Aventis CropScience and Aventis Animal Nutrition businesses as well as the remaining industrial activities. Along with our pharmaceutical business, Aventis will retain a 50% stake in the animal health business Merial, a joint venture with Merck & Co. (accounted for using the equity method).

ローム・アンド・ハース・カンパニー（ＲＯＨＭ ＡＮＤ ＨＡＡＳ ＣＯＭＰＡＮＹ）

オットー・ロームオットー・ハースがドイツで設立
米国支店設立

第一次大戦時に敵性資産没収を避けるため米国企業として独立

　（ドイツのRohm and Haasは後、Roehm社となり、現在Degussaの100%子会社）

ＭＭＡポリマー〜製品
　　仏エルフ・アトケム社と「ノルソハース（ＮｏｒｓｏＨａａｓ　製品部門）」＆
　　　「アトハース（ＡｔｏＨａａｓ　アクリル樹脂・板）」設立

　　　９８年　ノルソハースはローム・アンド・ハース
　　　　　　　　アトハースはエルフ・アトケムの全額出資会社に移行

アクリル酸モノマー
　　９９年６月　独ストックハウゼンと提携し折半出資合弁会社設立で合意

ＭＢＳ樹脂
　　８９年　呉羽化学と提携

Platts 2003/8/11

Rohm&Haas opens $20-mil Indian adhesives, sealants, coatings site

Rohm and Haas Co inaugurated Monday a $20-mil adhesives and sealants and coatings manufacturing and technical service facility in Taloja, India.

2006/12　Rohm and Haas joins Chinese additives JV

　　　2007/8　JinHaas officially begins operation - Contributes to Chinese plastics additives market

2007/5 Ceres and Rohm and Haas to study plant-based BioPRODUCTS

2007/7 Rohm and Haas Announces Construction of a New Polymer Emulsions Plant in Moscow Region, Russia

2007/9 Rohm and Haas Expands In India

2008/1　Rohm and Haas Opens Sanshui Manufacturing Facility in Guangdong, China 広東省仏山市三水区

2008/4　Rohm & Haas and Tasnee & Sahara Olefins Company Form JV to Make Acrylic Monomers in Saudi Arabia

2008/5　Rohm and Haas to Build Plant in Vietnam

2008/7 　Dow Acquires Rohm and Haas

Hoechst Aktiengesellschaft　　

　ヘキストの歴史　　　　　

Celanese　 　　　　　　　　　　　　　Hoechst Marion Roussel　

A long-standing chemical company - now part of the new Aventis
　　　　　http://www.hoechst.com/historie/historie_en12.htm#top

Aventis is the offshoot of the merger between the French chemical company Rhone-Poulenc and Hoechst Aktiengesellschaft of Frankfurt am Main. It is an international alliance of innovative companies whose interests are focused first and foremost on the various areas of the life sciences, notably drugs, agriculture/nutrition and animal health.

The company existing until 1999 as Hoechst Aktiengesellschaft was established in Frankfurt am Main only some fifty years ago.

It was back in 1987 that Hoechst took over the American Celanese Corporation and merged it with the old American Hoechst Corporation. This strengthening of the company's position on the American market was followed in 1995 by the purchase of the American pharmaceutical company Marion Merrell.

The final move was the spin-off of the remaining chemicals business into Celanese AG in the form of a demerger, thereby completing the radical realignment with the life sciences and at the same time clearing the way for the merger with Rhone-Poulenc to form Aventis.

Aventis　　http://www.archive.hoechst.com/english/index.html　　　

　　　　誕生 　　　　Aventisの事業分類

　　　　アベンティス クロップサイエンス社をバイエルに売却　　　

　Aventis Reduces its Shareholding in Rhodia　　

　　　Aventis Gains Additional Flexibility for Rhodia Stake Disposal

仏製薬サノフイ　アベンティス買収か　

　　　　仏サノフィ発表　アベンティス買収提案

Aventis Management Board rejects hostile offer from Sanofi-Synthelabo

Aventis Supervisory Board invites Novartis to enter into negotiations

アベンティス、豪ＣＳＬへのベーリング事業売却を完了

仏製薬合併、世界３位　サノフイ アベンティス買収へ　７兆円で合意

Aventis Supervisory Board Recommends Substantially Improved Offer from Sanofi-Synthelabo

「サノフィ・アベンティス」　2004/8/20に正式発足 　　　　　　　　　　 　Sanofi Aventis

(その後）

　　　　　　

アベンティスのライフサイエンス事業は2つの中核事業から成り立っています。一つは医療用医薬品、ワクチン、生物学的製剤および診断薬･機器から成る医薬品事業の分野です。同事業分野の売上は全体の70%以上を占めます。もう一方は農業関連事業であり、農作物保護･改良、動物用栄養製品および動物用医薬品から構成されています。
（アベンティス ベーリングジャパン　2000/12/21)

　　　　アベンティス、豪ＣＳＬへのベーリング事業売却を完了 　　

　　　　Aventis to sell animal nutrition business to CVC Capital Partners

　

Sanofi Aventis

1999/12/15

AVENTIS, NEW WORLD LEADER IN LIFE SCIENCES, LAUNCHED TODAY
　　　http://www.archive.hoechst.com/english/news/99/pm121599.html

Aventis, a new world leader in life sciences, was created today, December 15, 1999, following a meeting of Rhone-Poulenc shareholders who approved by an overwhelming majority (97.1%) the final steps required to complete the merger between Hoechst AG and Rhone-Poulenc S.A.

Key resolutions approved

Building on Positions of Strength

Aventis Pharma

Aventis Agriculture

November 15, 2001 Adisseo

Aventis to sell animal nutrition business to CVC Capital Partners
http://www.adisseo.com/index.asp?goto=%2Fpage%2FTListe01%2Easp%3Fdocid%3D6053%26p%3D4

Aventis and CVC Capital Partners, a leading European private equity company, have signed an agreement concerning the acquisition of Aventis Animal Nutrition by CVC Capital Partners. Subject to the required approval processes, the closing of the transaction is expected during the first quarter of 2002.

Aventis Animal Nutrition is one of the world's pioneers in animal nutrition, developing, manufacturing and marketing a broad range of nutritional feed additives, including the essential amino acid methionine as well as vitamins, vitamin premixes and feed enzymes.

日本経済新聞　2004/1/24

仏製薬サノフイ　アベンティス買収か　英仏紙報道　合併の可能性も

仏フィガロ紙、英フィナンシャル・タイムズなどは２３日、フランス製薬企業サノフィ・サンテラボがアベンティス買収を検討していると報じた。買収総額は数百億ドルの見通し。実現すれば米ファイザーに次いで世界２位の英グラクソスミスクラインと並ぶ売り上げ規模になる。

January 23 2004 Financial Times

Sanofi considers hostile bid for Aventis

The board of L'Oreal, the French cosmetics group that is a significant shareholder in Sanofi-Synthelabo, is to meet tomorrow to discuss the possibility of Sanofi bidding for rival drugs group Aventis.

L'Oreal owns 19.5 per cent of the shares in Sanofi and Total, the French oil group, has a 24.4 per cent stake. A shareholder agreement preventing either company selling its stakes expires in December.

---

サノフィ・サンテラボ 　Sanofi-Synthelabo
　　http://www.sanofi-synthelabo.co.jp/

フランスで第２位、ヨーロッパで第７位に位置付けられるグローバル製薬グループ

　フランスに本社を持つ、サノフィ・サンテラボ社は、フランスで第２位、ヨーロッパで第７位、世界でも第１６位に数えられる製薬グループです。
　全世界にわたる営業拠点は子会社を含め２５０拠点以上。３０、０００人の従業員を擁し、医療と人々の健康に貢献することを使命に、数々の新薬をお届けしています。

　サノフィ・サンテラボ社は、１９９９年、フランスの石油会社エルフ社（現 Total）の子会社であるサノフィ社Sanofiと、同じくフランスの総合化粧品会社、ロレアル社（L'Oreal）の子会社であるサンテラボ社Synthelaboが合併して誕生しました。合併にともない、診断薬、動物薬、化粧品の各事業部門を売却し、今日では医療品事業に特化した形で事業を展開しています。
　当社は、そのグローバルに確立されたブランド力のもとに、販売・マーケティング活動を幅広く展開。約１００カ国での販売実績を持ち、ヨーロッパ、ノース・アメリカ、日本、ラテン・アメリカ、アジア、アフリカにおいて、しっかりとした基盤を築き上げています。

1998/12/2 L'Oreal

L'Oreal: Sanofi and Synthelabo to merge: Elf Aquitaine and L'Oreal to hold 35.1% and 19.4% shareholdings respectively in the new group
http://www.loreal.com/us/press-room/full_article.asp?id_Art=1418&id_sousrubrique=1

日本経済新聞　2004/1/27 　　　　　Sanofiによる発表 　　　　　　既報

アベンティス買収提案．仏サノフィ発表　世界３位製薬誕生か

仏サノフィ・サンテラボは２６日、アベンティスに対し株式公開買い付け（ＴＯＢ）を実施すると発表した。実現すれば売上高規模で世界３位、豊富な新薬と強固な販売力を持つ巨大製薬企業が誕生し、新たな再編の引き金になる可能性もある。

日本の売り上げ合計２０００億円規模

2004/1/26 Aventis

Aventis Management Board rejects hostile offer from Sanofi-Synthelabo - Aventis Supervisory Board Chairman and Vice Chairman support the position of the Management Board
http://www.aventis.com/main/reject_offer_en.asp

January 26, 2004 　Sanofi-Synthelabo

Sanofi-Synthelabo announces offer for Aventis's shares

Presentation by : Jean- Francois DEHECQ Chairman & C. E. O.
http://en.sanofi-synthelabo.com/minisites/vh/en/pdf/equity_story_en.pdf

2004/4/2 Aventis

Aventis Supervisory Board unanimously invites Novartis to enter into negotiations about a potential combination - Aventis Supervisory Board decides on resolutions to be proposed to shareholders at the next General Meeting
http://www.aventis.com/main/page_disclaimer.asp?pageid=5616620040402182629&folderid=&lang=en

At its meeting today, the Supervisory Board of Aventis reviewed the current status of the unsolicited offer from Sanofi-Synthelabo of January 26, 2004, and reiterated that this bid is not in the best interests of Aventis, its shareholders and its employees.

During the meeting, the Management Board reported to the Supervisory Board on the discussions between Aventis and Novartis. After consideration of this report, the Supervisory Board unanimously mandated the Management Board to enter into negotiations with Novartis on the terms and conditions of a potential combination and to pursue discussions with the relevant authorities in France and Germany to address their specific issues. Of the 16 Supervisory Board members, 15 were present or represented at the meeting including the representative of Kuwait Petroleum Corp.

2004/4/26　日本経済新聞夕刊

仏製薬合併、世界３位　サノフイ、アベンティス買収へ　７兆円で合意

　欧州製薬大手アベンティスは２５日夜（日本時間２６日未明）、仏製薬企業サノフィ・サンテラボの買収提案受け入れを決めた。仏政府の仲介でサノフィが買収額を当初の４７０億ユーロ（約６兆２千億円）から約１４％引き上げ、約５４０億ユーロ（約７兆円）とし、拒否の姿勢を続けてきたアベンティスも最終的に受諾した。両社の統合により、売り上げ規模で世界３位の製薬企業が誕生する。


世界の大手医薬品メー力一

（注）米調査会社 ＩＭＳヘルスの販売価格べ一ス売上高シェアランキングを基に作成

2004/4/26 Aventis

Aventis Supervisory Board Recommends Substantially Improved Offer from Sanofi-Synthelabo in Order to Create Sanofi-Aventis
http://www.aventis.com/main/page_disclaimer.asp?pageid=82123720040425224127&folderid=&lang=en

On April 25, 2004, Aventis and Sanofi-Synthelabo agreed on a substantially improved offer as well as a balanced governance structure. After reviewing this new offer, the Management Board and the Supervisory Board decided to recommend this offer to Aventis shareholders.

日本経済新聞　2004/8/13

「サノフィ・アベンティス」２０日に正式発足　サノフィが買収成功

　仏製薬企業サノフィ・サンテラボは１２日、欧州製薬大手アベンティスの買収に成功したと発表した。同日、仏金融市場当局がサノフィによるアベンティス株式取得状況の最終集計結果を公表、約９割の取得を確認した。サノフィは今月２０日付で「サノフィ・アベンティス」と社名を変更、売上高で最大手の米ファイザー、英グラクソスミスクラインに次ぐ世界三位の製薬会社が正式発足する。
　サノフィ・アベンティスの会長兼最高経営責任者（ＣＥＯ）にはデュエック・サノフィ会長兼ＣＥＯが就任、アベンティスのランドウ会長は取締役となる。

02/02/2004　Aventis　　　　　　　　　　　　　　　　　　　　　　参考

Aventis Gains Additional Flexibility for Rhodia Stake Disposal
http://www.aventis.com/main/page.asp?pageid=86796620040130171428&lang=en

（注　Aventeis誕生の条件であった Rhodia株売却の代わりに、Wackerの株式売却）

On January 30, 2004, the European Commission agreed to replace a commitment obliging Aventis to sell its 15.3% stake in Rhodia with a commitment to divest its 49% stake in Wacker-Chemie within a confidential timeframe of several years.

The European Commission had agreed to the formation of Aventis through the combination of Rhone-Poulenc and Hoechst in 1999, subject to certain commitments (IP/99/626). One of the commitments related to Aventis reducing its stake in Rhodia to below 5% by April 2004. In addition, the Commission required that Wacker's operations be maintained separately from those of Rhodia, until the Aventis stake in Rhodia is divested.

2003/11/5　Nalco

Nalco Aquisition By Private Equity Group Complete
http://www.nalco.com/headlinesdetail.asp

The private equity group consisting of The Blackstone Group, Apollo Management, L.P., and Goldman Sachs Capital Partners announced today that its acquisition of Ondeo Nalco Company from Suez, S.A. is complete. The group tendered an offer for Ondeo Nalco in September for $4.2 billion. As of the closing of the sale, the officially renamed Nalco Company will operate as a privately held, independent business.